thrombin-activable factor X (Novo Nordisk)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namethrombin-activable factor X (Novo Nordisk)
Drug Alias Namethrombin-activable factor X (INSERM)thrombin-activable factor X (C2X)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor X modulators
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC2X PharmaInsermNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A